Clear Genetics

Clear Genetics developed a software platform to enhance the delivery and accessibility of genetic services for patients, clinics, and healthcare providers. The company was founded in 2016 by Israeli entrepreneurs Moran Snir, Guy Snir, and Motti Shohat M.D. Moran Snir, who served as CEO, has a background in biomedical engineering and an MBA from Wharton, and was inspired by her upbringing in a family of medical geneticists to simplify the complexities of genetic testing for the public. Guy Snir, the COO, brought experience from senior product roles at major tech companies like Twitter and Google. The founders identified a growing need for scalable solutions in the burgeoning genetic testing market.

The company's core business centered on a HIPAA-compliant software-as-a-service (SaaS) platform designed to automate and streamline the genetic testing process. A key feature was 'Gia', an AI-powered chatbot developed in collaboration with genetic counselors. Gia guided patients through the entire journey, from providing consent and personalized risk assessments to explaining insurance benefits and interpreting test results in an easy-to-understand conversational format. For clinicians and health systems, Clear Genetics offered the 'Clinic Hub', a portal to help manage patient care, including tools for automated patient triage. The company's clients included prominent health systems and clinics like Geisinger and Huntsman Cancer Institute, as well as commercial labs.

Clear Genetics's business model focused on licensing its software to healthcare providers, enabling them to handle a larger volume of patients more efficiently. The platform acted as a digital navigator, bridging the gap between complex genetic information and the patients and doctors who need to act on it. After participating in the Y Combinator accelerator program, the company reached a significant milestone in November 2019 when it was acquired by Invitae Corporation, a leading medical genetics company, for approximately $50 million in a cash and stock deal. The acquisition was a strategic move by Invitae to integrate Clear Genetics's patient-centric workflow solutions to help scale its own operations and bring genetic information further into mainstream medicine.

Keywords: genetic services software, patient engagement platform, clinical workflow automation, genetic counseling chatbot, Gia chatbot, medical chatbots, digital health, patient triage software, personalized risk assessment, Invitae acquisition, Moran Snir, Guy Snir, Y Combinator, health-tech, genetic testing support, HIPAA-compliant software, patient education tools, healthcare SaaS, genetics data management, clinician support tools